Maple-Brown Abbott Asian Equity Income Fund – Institutional Euro

The Fund is invested in companies listed (or expected to be listed) across Asia that we believe have sustainable and growing income streams and the potential for long-term capital growth and is actively managed.

We believe one of the key identifiers of strong total returns of Asian equities is dividend growth. The Fund’s investment universe comprises companies across the Asian region with a market capitalisation typically above US$1 billion dollars. To narrow the investment universe, we apply two distinct quantitative screening models to identify those companies with both the ability to pay a sustainable and growing income streams, and the intention to reward shareholders with an attractive dividend profile going forward. These dividend-focused screens are complemented by detailed bottom-up analysis including financial forecasts, an assessment of management quality, industry structure and ESG factors. 

We manage the Fund on a ‘benchmark unaware’ basis and will typically hold 25–40 stocks.

Investment objective

The Fund aims to deliver an attractive total return, after fees, over a rolling five-year period whilst maintaining a dividend yield in excess of the Benchmark.

Fund facts
Fund inception date^19/10/2007Class inception date^19/10/2007
Base currencyUSDClass currencyEUR
ISIN codeIE00B284YS39BenchmarkMSCI All Countries Asia Excluding Japan Net Index (US$)
Minimum initial subscriptionUSD $ 1,000,000 or EUR equivalentAnnual management charge %0.75

^The Fund’s name, investment objective and investment policies changed on 23 May 2022.

Portfolio Managers

A team of experienced and dedicated investment professionals.

howard Ho | Portfolio Manager, Asian Equity Income | Maple-Brown Abbott
Howard Ho
Portfolio Manager, Asian Equity Income
Will Main | Head of Asia | Maple-Brown Abbott
Will Main
Head of Asia

Fund performance^

as at 30/04/2024

Performance in EUR1 mth %3 mths %1 yr % p.a.Since inception % p.a.*

^Past performance is not a reliable indicator of future performance. No warranty can be given for future performance. Returns are volatile and may fluctuate quickly and significantly. The fund’s performance is based on the movement in net asset value per share and is before tax and after all fees and charges. Tax credits are not included in the performance figures. Source: Maple-Brown Abbott and MSCI

* Inception date is 23 May 2022.
The MSCI information may not be reproduced or redisseminated in any form and may not be used as a basis for or a component of any financial instruments or products or indices. None of the MSCI information is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such. Historical data and analysis should not be taken as an indication or guarantee of any future performance analysis, forecast or prediction. The MSCI information is provided on an “as is” basis and the user of this information assumes the entire risk of any use made of this information. MSCI, each of its affiliates and each other person involved in or related to compiling, computing or creating any MSCI information (collectively, the “MSCI Parties”) expressly disclaims all warranties (including, without limitation, any warranties of originality, accuracy, completeness, timeliness, non-infringement merchantability and fitness for a particular purpose) with respect to this information. Without limiting any of the foregoing, in no event shall any MSCI Party have any liability for any direct, indirect, special, incidental, punitive, consequential (including, without limitation, lost profits) or any other damages. (

 Forms and fund information

Proxy voting outcomes 

The table below shows how we have exercised our vote for listed shares held in the Asian Equity Income Fund for the 12 months to 30 June 2023.

MeetingsResolutionsVoted with ManagementVoted against ManagementAbstained
Number 47399363340

The data reflects where we have voted for or against management recommendations. Of the 34 "against" votes, 35% related to capital structuring, 24% related to the election of a director, and the remainder related to other governance matters.

Interested in investing with us?